Loading…

Gliclazide

The crystal structure of gliclazide, N-[(perhydrocyclopenta [c]pyrrol-2-yl)aminocarbonyl]-p-toluenesulfonamide, C15H21B3O3S, a second-generation oral hypoglycemic agent, contains discrete molecules with normal molecular dimensions. Both of the five-membered fused rings adopt envelope conformations....

Full description

Saved in:
Bibliographic Details
Published in:Acta crystallographica. Section C, Crystal structure communications Crystal structure communications, 1999-01, Vol.55 (1), p.74-75
Main Authors: Parvez, M., Arayne, M. S., Zaman, M. K., Sultana, N.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4819-cea6ae3b64e7e380aaceb2686ee731798b86cfb52ddf7bf9063addf0aaed7ea23
cites
container_end_page 75
container_issue 1
container_start_page 74
container_title Acta crystallographica. Section C, Crystal structure communications
container_volume 55
creator Parvez, M.
Arayne, M. S.
Zaman, M. K.
Sultana, N.
description The crystal structure of gliclazide, N-[(perhydrocyclopenta [c]pyrrol-2-yl)aminocarbonyl]-p-toluenesulfonamide, C15H21B3O3S, a second-generation oral hypoglycemic agent, contains discrete molecules with normal molecular dimensions. Both of the five-membered fused rings adopt envelope conformations. The molecules are linked into chains by intermolecular hydrogen bonds involving amino-H atoms, with N...O separations of 2.967 (3) and 2.949 (3) A.
doi_str_mv 10.1107/S0108270198009883
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69599168</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69599168</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4819-cea6ae3b64e7e380aaceb2686ee731798b86cfb52ddf7bf9063addf0aaed7ea23</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMo7of-AC-exFt10rT5OC6rW4VFD66KXkKaTqHa_TDZouuvN6WLCh48zcA8zzvMEHJE4YxSEOd3QEHGAqiSAEpKtkP6lANEqUjVLum346id98jA-xcAiOOY7ZMeBUgkFapPBlld2dp8VgUekL3S1B4Pt3VI7ieXs_FVNL3NrsejaWSDoyKLhhtkOU9QIJNgjMU85pIjChYyZS65LfM0LopS5KUCzkxoA4eFQBOzITntcldu-dagX-t55S3WtVngsvGaq1QpymUAaQdat_TeYalXrpobt9EUdPsA_ecBwTnehjf5HItfRndxAE62gPHW1KUzC1v5H45zmigRMNlh71WNm_8X69HTeJIFtd0QdWrl1_jxrRr3qrlgItWPN5m-eEieqZhxLdkXBJ6AFg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69599168</pqid></control><display><type>article</type><title>Gliclazide</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Parvez, M. ; Arayne, M. S. ; Zaman, M. K. ; Sultana, N.</creator><creatorcontrib>Parvez, M. ; Arayne, M. S. ; Zaman, M. K. ; Sultana, N.</creatorcontrib><description>The crystal structure of gliclazide, N-[(perhydrocyclopenta [c]pyrrol-2-yl)aminocarbonyl]-p-toluenesulfonamide, C15H21B3O3S, a second-generation oral hypoglycemic agent, contains discrete molecules with normal molecular dimensions. Both of the five-membered fused rings adopt envelope conformations. The molecules are linked into chains by intermolecular hydrogen bonds involving amino-H atoms, with N...O separations of 2.967 (3) and 2.949 (3) A.</description><identifier>ISSN: 0108-2701</identifier><identifier>EISSN: 1600-5759</identifier><identifier>DOI: 10.1107/S0108270198009883</identifier><identifier>PMID: 10048179</identifier><identifier>CODEN: ACSCEE</identifier><language>eng</language><publisher>5 Abbey Square, Chester, Cheshire CH1 2HU, England: International Union of Crystallography</publisher><subject>Biological and medical sciences ; Condensed matter: structure, mechanical and thermal properties ; Crystallography, X-Ray ; Exact sciences and technology ; General and cellular metabolism. Vitamins ; Gliclazide - chemistry ; Heterocyclic compounds ; Hypoglycemic Agents - chemistry ; Medical sciences ; Molecular Structure ; Organic compounds ; Pharmacology. Drug treatments ; Physics ; Structure of solids and liquids; crystallography ; Structure of specific crystalline solids</subject><ispartof>Acta crystallographica. Section C, Crystal structure communications, 1999-01, Vol.55 (1), p.74-75</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4819-cea6ae3b64e7e380aaceb2686ee731798b86cfb52ddf7bf9063addf0aaed7ea23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1661497$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10048179$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Parvez, M.</creatorcontrib><creatorcontrib>Arayne, M. S.</creatorcontrib><creatorcontrib>Zaman, M. K.</creatorcontrib><creatorcontrib>Sultana, N.</creatorcontrib><title>Gliclazide</title><title>Acta crystallographica. Section C, Crystal structure communications</title><addtitle>Acta Cryst. C</addtitle><description>The crystal structure of gliclazide, N-[(perhydrocyclopenta [c]pyrrol-2-yl)aminocarbonyl]-p-toluenesulfonamide, C15H21B3O3S, a second-generation oral hypoglycemic agent, contains discrete molecules with normal molecular dimensions. Both of the five-membered fused rings adopt envelope conformations. The molecules are linked into chains by intermolecular hydrogen bonds involving amino-H atoms, with N...O separations of 2.967 (3) and 2.949 (3) A.</description><subject>Biological and medical sciences</subject><subject>Condensed matter: structure, mechanical and thermal properties</subject><subject>Crystallography, X-Ray</subject><subject>Exact sciences and technology</subject><subject>General and cellular metabolism. Vitamins</subject><subject>Gliclazide - chemistry</subject><subject>Heterocyclic compounds</subject><subject>Hypoglycemic Agents - chemistry</subject><subject>Medical sciences</subject><subject>Molecular Structure</subject><subject>Organic compounds</subject><subject>Pharmacology. Drug treatments</subject><subject>Physics</subject><subject>Structure of solids and liquids; crystallography</subject><subject>Structure of specific crystalline solids</subject><issn>0108-2701</issn><issn>1600-5759</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LxDAQhoMo7of-AC-exFt10rT5OC6rW4VFD66KXkKaTqHa_TDZouuvN6WLCh48zcA8zzvMEHJE4YxSEOd3QEHGAqiSAEpKtkP6lANEqUjVLum346id98jA-xcAiOOY7ZMeBUgkFapPBlld2dp8VgUekL3S1B4Pt3VI7ieXs_FVNL3NrsejaWSDoyKLhhtkOU9QIJNgjMU85pIjChYyZS65LfM0LopS5KUCzkxoA4eFQBOzITntcldu-dagX-t55S3WtVngsvGaq1QpymUAaQdat_TeYalXrpobt9EUdPsA_ecBwTnehjf5HItfRndxAE62gPHW1KUzC1v5H45zmigRMNlh71WNm_8X69HTeJIFtd0QdWrl1_jxrRr3qrlgItWPN5m-eEieqZhxLdkXBJ6AFg</recordid><startdate>19990115</startdate><enddate>19990115</enddate><creator>Parvez, M.</creator><creator>Arayne, M. S.</creator><creator>Zaman, M. K.</creator><creator>Sultana, N.</creator><general>International Union of Crystallography</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990115</creationdate><title>Gliclazide</title><author>Parvez, M. ; Arayne, M. S. ; Zaman, M. K. ; Sultana, N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4819-cea6ae3b64e7e380aaceb2686ee731798b86cfb52ddf7bf9063addf0aaed7ea23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>Condensed matter: structure, mechanical and thermal properties</topic><topic>Crystallography, X-Ray</topic><topic>Exact sciences and technology</topic><topic>General and cellular metabolism. Vitamins</topic><topic>Gliclazide - chemistry</topic><topic>Heterocyclic compounds</topic><topic>Hypoglycemic Agents - chemistry</topic><topic>Medical sciences</topic><topic>Molecular Structure</topic><topic>Organic compounds</topic><topic>Pharmacology. Drug treatments</topic><topic>Physics</topic><topic>Structure of solids and liquids; crystallography</topic><topic>Structure of specific crystalline solids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Parvez, M.</creatorcontrib><creatorcontrib>Arayne, M. S.</creatorcontrib><creatorcontrib>Zaman, M. K.</creatorcontrib><creatorcontrib>Sultana, N.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta crystallographica. Section C, Crystal structure communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Parvez, M.</au><au>Arayne, M. S.</au><au>Zaman, M. K.</au><au>Sultana, N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gliclazide</atitle><jtitle>Acta crystallographica. Section C, Crystal structure communications</jtitle><addtitle>Acta Cryst. C</addtitle><date>1999-01-15</date><risdate>1999</risdate><volume>55</volume><issue>1</issue><spage>74</spage><epage>75</epage><pages>74-75</pages><issn>0108-2701</issn><eissn>1600-5759</eissn><coden>ACSCEE</coden><abstract>The crystal structure of gliclazide, N-[(perhydrocyclopenta [c]pyrrol-2-yl)aminocarbonyl]-p-toluenesulfonamide, C15H21B3O3S, a second-generation oral hypoglycemic agent, contains discrete molecules with normal molecular dimensions. Both of the five-membered fused rings adopt envelope conformations. The molecules are linked into chains by intermolecular hydrogen bonds involving amino-H atoms, with N...O separations of 2.967 (3) and 2.949 (3) A.</abstract><cop>5 Abbey Square, Chester, Cheshire CH1 2HU, England</cop><pub>International Union of Crystallography</pub><pmid>10048179</pmid><doi>10.1107/S0108270198009883</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0108-2701
ispartof Acta crystallographica. Section C, Crystal structure communications, 1999-01, Vol.55 (1), p.74-75
issn 0108-2701
1600-5759
language eng
recordid cdi_proquest_miscellaneous_69599168
source Wiley-Blackwell Read & Publish Collection
subjects Biological and medical sciences
Condensed matter: structure, mechanical and thermal properties
Crystallography, X-Ray
Exact sciences and technology
General and cellular metabolism. Vitamins
Gliclazide - chemistry
Heterocyclic compounds
Hypoglycemic Agents - chemistry
Medical sciences
Molecular Structure
Organic compounds
Pharmacology. Drug treatments
Physics
Structure of solids and liquids
crystallography
Structure of specific crystalline solids
title Gliclazide
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A42%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gliclazide&rft.jtitle=Acta%20crystallographica.%20Section%20C,%20Crystal%20structure%20communications&rft.au=Parvez,%20M.&rft.date=1999-01-15&rft.volume=55&rft.issue=1&rft.spage=74&rft.epage=75&rft.pages=74-75&rft.issn=0108-2701&rft.eissn=1600-5759&rft.coden=ACSCEE&rft_id=info:doi/10.1107/S0108270198009883&rft_dat=%3Cproquest_cross%3E69599168%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4819-cea6ae3b64e7e380aaceb2686ee731798b86cfb52ddf7bf9063addf0aaed7ea23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69599168&rft_id=info:pmid/10048179&rfr_iscdi=true